Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I / II Clinical Trial of GAIA-102 for Advanced and Relapse NSCLC

NCT05207371 is registered in ClinicalTrials.gov with GAIA BioMedicine Inc. as lead sponsor.

NCT NCT05207371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05207371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I / II Clinical Trial of GAIA-102 for Advanced and Relapse NSCLC
Lead sponsor
GAIA BioMedicine Inc.
Phase
Phase 1/2
Overall status
Terminated
Start date
December 1, 2021
Completion date
March 6, 2026
Enrollment
22 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cell therapy, nsclc